(2S)-6-Fluoro-2-chromanecarboxylic acid | CAS:129101-36-6

We serve (2S)-6-Fluoro-2-chromanecarboxylic acid CAS:129101-36-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
 (2S)-6-Fluoro-2-chromanecarboxylic acid

Chemical Name:    (2S)-6-Fluoro-2-chromanecarboxylic acid
CAS.NO:129101-36-6
Synonyms:
nebulic acid
(S)-5-(aminomethyl)-2-pyrrolidinone
(S)-5-Aminomethyl-pyrrolidin-2-one
(+)-(S)-6-fluoro-3,4-dihydro-2H-1-benzopyran-2-carboxylic acid
2-Pyrrolidinone,5-(aminomethyl)-,(5S)
(S)-5-(aminomethyl)-2-pyrrolidone
(S)-6-fluorochroman-2-carboxylic acid

Molecular Formula: C10H9FO3
Molecular Weight: 196.17500

Physical and Chemical Properties:
Density:1.364±0.06 g/cm3
Boiling point: 358.0±42.0 °C(
Melting point: /
Flash point: /
Refractive index: 1.568

Specification:
Appearance: White solid
Purity:≥99%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage: Keep away from heat, sparks, and flame. Keep away from sources of ignition. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application:
Intermediates of Nebivolol hydrochloride CAS: 152520-56-4



Contact us for information like (2S)-6-Fluoro-2-chromanecarboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(S)-6-fluorochroman-2-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(S)-5-(aminomethyl)-2-pyrrolidone Use and application,(S)-6-fluorochroman-2-carboxylic acid technical grade,usp/ep/jp grade.


Related News: The drug substance is an active product that has completed the synthetic route, and the intermediate is a product in one place in the synthetic route.(3-Fluoro-4'-butyl[1,1'-biphenyl]-4-yl)boronic acid manufacturer “Our collaboration with Mankind demonstrates our commitment towards providing novel, innovative treatment options for efficient diabetes management,” Glenmark Pharmaceuticals President, India Formulations, Middle East and Africa Sujesh Vasudevan said.Ethyl 2,6-Dichloro-5-Fluoro-Pyridine-3-Acetoacetate supplier With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout.Vinyltrimethoxysilane vendor Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries.A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018.